Archives

November 4, 2010

Cycloset Data to Be Presented in Poster Session at 8th Annual World Congress on Insulin Resistance, Diabetes & CVD

SAN DIEGO & TIVERTON, R.I. --(BUSINESS WIRE)-- Santarus, Inc. (NASDAQ:SNTS) and VeroScience LLC today announced that analyses of 379-patient subset...
Read More
September 8, 2010

Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET

SAN DIEGO & BRISTOL, Tenn. & TIVERTON, R.I., Sep 08, 2010 (BUSINESS WIRE) -- Santarus, Inc. (NASDAQ: SNTS), S2 Therapeutics,...
Read More